Clinical study on the effect of iodine-enhanced contrast agent on non-invasive hemodynamics in elderly patients with cardiovascular disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300070704

Enrollment

Unknown

Registered

2023-04-20

Start date

2021-09-13

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Over 60 years old; ? Patients with coronary CTA in our hospital

Exclusion criteria

Exclusion criteria: ? people with known history of iodine allergy; ? Patients with skin disease or allergy to electrode adhesive; ? Patients with severe thoracic deformity, hemothorax, chest wall edema, pleural effusion, obesity and other interference with electronic signal transmission; ? Those who have had serious cerebrovascular events in recent 3 months; ? Severe liver and kidney diseases, severe arrhythmia and advanced tumor patients; ? Patients with pacemakers; ? Temporary use before examination ß Patients with receptor blockers. ? Those who cannot cooperate.

Design outcomes

Primary

Measure	Time frame
systolic pressure;diastolic pressure;mean arterial pressure;heart rate;Cardiac output;Stroke output;Peripheral vascular resistance;	—

Countries

China

Contacts

Public Contactlixue/chenlan

Army Characteristic Medical Center

Lixue92813621@163.com+86 13677675776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026